D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.68B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$875M |
| 4 |
Tesla
TSLA
|
+$835M |
| 5 |
Eli Lilly
LLY
|
+$643M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$939M |
| 2 |
Palantir
PLTR
|
+$668M |
| 3 |
Apple
AAPL
|
+$644M |
| 4 |
Workday
WDAY
|
+$525M |
| 5 |
Spotify
SPOT
|
+$451M |
Sector Composition
| 1 | Technology | 20.55% |
| 2 | Consumer Discretionary | 13.27% |
| 3 | Healthcare | 12.29% |
| 4 | Financials | 8.39% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Macy's
M
$4.54B
| $3.26M | ﹤0.01% |
192,820
-1,873,932
| -91% | -$31.7M |
|
|
AVDL
1402
Avadel Pharmaceuticals
AVDL
$1.5B
| $3.25M | ﹤0.01% |
309,658
+183,496
| +145% | +$1.93M |
|
1403
NCR Voyix
VYX
$1.77B
| $3.25M | ﹤0.01% |
235,142
-142,626
| -38% | -$1.97M |
|
1404
Astronics
ATRO
$1.41B
| $3.25M | ﹤0.01% |
203,341
+153,839
| +311% | +$2.46M |
|
1405
NVR
NVR
$23.3B
| $3.24M | ﹤0.01% |
396
+253
| +177% | +$2.07M |
|
1406
Mission Produce
AVO
$900M
| $3.23M | ﹤0.01% |
225,025
+110,198
| +96% | +$1.58M |
|
|
KREF
1407
KKR Real Estate Finance Trust
KREF
$630M
| $3.22M | ﹤0.01% |
319,230
+37,476
| +13% | +$379K |
|
1408
Spectrum Brands
SPB
$1.29B
| $3.21M | ﹤0.01% |
38,022
-6,122
| -14% | -$517K |
|
1409
Liberty Media Series A
FWONA
$22.5B
| $3.21M | ﹤0.01% |
38,204
-26,760
| -41% | -$2.25M |
|
|
CHCT
1410
Community Healthcare Trust
CHCT
$445M
| $3.2M | ﹤0.01% |
166,387
-8,837
| -5% | -$170K |
|
1411
Ducommun
DCO
$1.39B
| $3.2M | ﹤0.01% |
+50,201
| New | +$3.2M |
|
1412
MarketAxess Holdings
MKTX
$6.91B
| $3.19M | ﹤0.01% |
14,131
-54,959
| -80% | -$12.4M |
|
1413
Warrior Met Coal
HCC
$3.04B
| $3.19M | ﹤0.01% |
58,877
+7,426
| +14% | +$403K |
|
1414
GXO Logistics
GXO
$5.84B
| $3.19M | ﹤0.01% |
+73,280
| New | +$3.19M |
|
1415
Brady Corp
BRC
$3.74B
| $3.18M | ﹤0.01% |
43,050
-36,421
| -46% | -$2.69M |
|
1416
M/I Homes
MHO
$4.07B
| $3.18M | ﹤0.01% |
+23,900
| New | +$3.18M |
|
1417
CryoPort
CYRX
$433M
| $3.18M | ﹤0.01% |
408,385
+68,474
| +20% | +$533K |
|
1418
Ethan Allen Interiors
ETD
$742M
| $3.17M | ﹤0.01% |
112,710
+70,664
| +168% | +$1.99M |
|
1419
Design Therapeutics
DSGN
$343M
| $3.16M | ﹤0.01% |
512,330
-70,528
| -12% | -$435K |
|
1420
IAC Inc
IAC
$2.89B
| $3.16M | ﹤0.01% |
+89,198
| New | +$3.16M |
|
1421
McEwen Inc.
MUX
$748M
| $3.16M | ﹤0.01% |
405,661
-134,304
| -25% | -$1.04M |
|
1422
FS KKR Capital
FSK
$4.91B
| $3.15M | ﹤0.01% |
145,191
-126,667
| -47% | -$2.75M |
|
1423
Dyne Therapeutics
DYN
$1.87B
| $3.15M | ﹤0.01% |
133,772
+60,732
| +83% | +$1.43M |
|
1424
Vera Therapeutics
VERA
$1.52B
| $3.15M | ﹤0.01% |
74,476
-55,990
| -43% | -$2.37M |
|
1425
Clean Energy Fuels
CLNE
$526M
| $3.12M | ﹤0.01% |
1,241,708
+450,143
| +57% | +$1.13M |
|